Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ · Healthcare
Aurinia Pharmaceuticals Inc. Total Liabilities 2018–2025
Aurinia Pharmaceuticals Inc. annual/quarterly total liabilities history from 2019 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aurinia Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 170.3M, a 1.68% decrease year-over-year.
- Aurinia Pharmaceuticals Inc. total liabilities for 2025 were 170.3M, a 1.68% decrease from 2024.
- Aurinia Pharmaceuticals Inc. total liabilities for 2024 were 173.2M, a 1.80% increase from 2023.
- Aurinia Pharmaceuticals Inc. total liabilities for 2023 were 170.1M, a 160.00% increase from 2022.
- Aurinia Pharmaceuticals Inc. total liabilities for 2022 were 65.4M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aurinia Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $170 |
| 2024 | $173 |
| 2023 | $170 |
| 2022 | $65 |
| 2021 | $64 |
| 2020 | $56 |
| 2019 | $26 |
| Aurinia Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $170 |
| 2024-12-31 | $173 |
| 2023-12-31 | $170 |
| 2022-12-31 | $65 |
| 2021-12-31 | $64 |
| 2020-12-31 | $56 |
| 2019-12-31 | $26 |
Aurinia Pharmaceuticals Inc. Total Liabilities — FAQ
Aurinia Pharmaceuticals Inc. (AUPH) total liabilities over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AUPH's total liabilities history?
The chart and table above show Aurinia Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.